MedTrace Logo

Biomarkers in Young Patients With Neuroblastoma

NCT01169376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in young patients with neuroblastoma.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

DNA methylation analysis

GENETIC

RNA analysis

GENETIC

comparative genomic hybridization

GENETIC

mutation analysis

GENETIC

polymorphism analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • John M. Maris, MD · Children's Hospital of Philadelphia

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169376 on ClinicalTrials.gov